Tower Research Capital (TRC)’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
Tower Research Capital (TRC)'s CLBT Position: Q3 2026 in Review
Tower Research Capital (TRC) opened a new position in Cellebrite (CLBT) in Q3 2026: 24,816 shares worth $279K. The stake represents ﹤0.01% of the portfolio and ranks #2134 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in CLBT as recently as Q1 2026.
Tower Research Capital (TRC) first reported a position in CLBT in Q3 2021 and has held it in 10 quarters since. The position peaked at $418K in Q2 2024. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.
- Tower Research Capital (TRC) held 24,816 shares of Cellebrite worth $279K as of Q3 2026.
- Cellebrite was a new Tower Research Capital (TRC) position in Q3 2026.
- Cellebrite made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #2134 holding.
- Tower Research Capital (TRC) first reported a position in Cellebrite in Q3 2021 and has held it in 10 quarters since.
- Tower Research Capital (TRC)'s Cellebrite position peaked at $418K in Q2 2024.
- 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.